Role of hypoxia in the tumor microenvironment and... (2022 study) Skip to main content
Review Front Oncol 2022

Role of hypoxia in the tumor microenvironment and targeted therapy

Chen G, Wu K, Li H, Xia D, He T, Front Oncol, 2022

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

The authors wrote a review of how low oxygen (hypoxia) inside solid tumors affects tumor behavior and the tumor's surroundings, and they listed the treatments that target it.

What They Found

This narrative review of hypoxia in the tumor microenvironment reports that hypoxia is widespread in solid tumors and is linked to several tumor behaviors, with no patient numbers or outcome figures given. The abstract says many factors in the tumor microenvironment that affect tumor cell behavior are closely related to hypoxia. It states that hypoxia plays an important role in tumor cell metabolism and in resisting cell death, and that it works to inhibit the immune response in the tumor. The authors looked at immune cells, cell metabolism, oxidative stress and hypoxia inducible factor (HIF), and listed the therapeutic targets and signal pathways found so far.

What This Means for Canadian Patients

The abstract names hyperbaric medicine only as one item in a list of current therapies that target hypoxia, alongside glycolysis inhibitors, anti-angiogenesis drugs, HIF inhibitors and hypoxia-activated prodrugs. It gives no details on how hyperbaric medicine is used, what pressure or number of sessions might apply, or whether it helps people with cancer. Patients with a solid tumor should take questions about any treatment to their cancer care team.

Canadian Relevance

No direct Canadian connection identified.

Study Limitations

The abstract describes a review of existing research, not a new trial, and it reports no patient data or measured results on hyperbaric medicine, so it cannot show whether that therapy works for tumors.

This plain-language summary was generated with AI assistance from the study's abstract; it has not been individually reviewed by a clinician. Always consult the source study and a qualified healthcare professional. See our editorial policy.

Was this summary helpful?

Study Details

Study Type Review
Category Systematic Reviews
Source Pubmed
PubMed ID 36212414
Year Published 2022
Journal Front Oncol

Cite This Study

Share

Find a Canadian Clinic

Browse verified hyperbaric facilities across Canada.

View Canadian Facilities

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.

Last updated: April 17, 2026 | Reviewed by: Canada Hyperbarics Editorial Team | Editorial process | Research sources | Counts & methodology